R3T3 cells, a mouse fibroblast cell line, express the type 2 angiotens
in II receptor (AT(2)), but not the AT(1) subtype. We previously repor
ted that expression of AT(2) sites in these cells were regulated by va
rious conditions: 1. The number of AT(2) sites increased considerably
when cells were contact-inhibited; 2. Stimulation of R3T3 cells with v
arious mitogens caused a rapid decline of AT(2) binding sites; and 3.
Stimulation of cells with angiotensin ligands resulted in upregulation
of the AT(2) sites. In this study, to determine if altered AT(2) expr
ession is under transcriptional, posttranscriptional, or translational
control, we examined the level of AT(2) mRNA in R3T3 cells in respons
e to various treatments. There was a 200-fold increase in AT(2) mRNA l
evels in quiescent cells as compared to growing cells. Results from nu
clear run-on assays suggested that the differences in AT(2) mRNA level
s were primarily caused by changes in the rate of AT(2) gene transcrip
tion. Stimulation of cells with fibroblast growth factor caused an app
roximate threefold reduction of AT(2) mRNA levels, and also increased
the rate of degradation of AT(2) mRNA, which correlated with the decre
ase in AT(2) binding activity seen under these conditions. However, wh
ereas treatment with angiotensin ligands increased AT(2) binding activ
ity, the level of AT(2) transcripts did not increase. This pattern of
expression implies that regulation of AT(2) receptors occurs at multip
le levels, involving translational and/or posttranslational as well as
transcriptional control, and further affords the cell the ability to
rapidly modulate the number of AT(2) binding sites in response to chan
ging extracellular conditions.